Timber Pharmaceuticals to Present at the Virtual Summer Summit 


Presentation on Tuesday, June 9th at 2:10pm ETWOODCLIFF LAKE, NJ, June 03, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Timber Pharmaceuticals, Inc. (“Timber” or the “Company”) (NYSE American: TMBR), a biopharmaceutical company focused on the development and commercialization of treatments for orphan dermatologic diseases, today announced that John Koconis, CEO of Timber, will present a corporate overview of the company, its development pipeline and near-term milestones at the Virtual Summer Summit on Tuesday, June 9th, 2020 at 2:10pm ET.The Virtual Summer Summit will take place entirely online and feature over 500 registered executives and qualified investors viewing virtual company presentations and attending one-on-one meetings. To attend the virtual presentation, please go to the following link on Tuesday, June 9th at 2:10pm ET: https://www.webcaster4.com/Webcast/Page/2038/35017For more information, please visit: www.microcapconf.com.About Timber Pharmaceuticals, Inc.Timber Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of treatments for orphan dermatologic diseases. The company’s investigational therapies have proven mechanisms-of-action backed by decades of clinical experience and well-established CMC (chemistry, manufacturing, and control) and safety profiles. Timber is initially focused on developing non-systemic treatments for rare dermatologic diseases including congenital ichthyosis (CI), facial angiofibromas in tuberous sclerosis complex (TSC), and localized scleroderma. For more information, visit www.timberpharma.com.For more information, contact:Timber Pharmaceuticals, Inc. 
John Koconis 
Chief Executive Officer
[email protected]
Investor Relations:
Stephanie Prince
PCG Advisory
(646) 762-4518
[email protected]
Media Relations: 
Adam Daley
Berry & Company Public Relations 
212-253-8881
[email protected]


Bay Street News

Contact Us

We're not around right now. But you can send us an email and we'll get back to you, asap.

Not readable? Change text. captcha txt

Start typing and press Enter to search